Tomonori Habuchi

Amed Crest
Tokyo, 1020004, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 295 publications

Subsequent systemic therapy initiation after first-line discontinuation in metastatic renal cell carcinoma: insights from a Japanese real-world cohort.

Subsequent systemic therapy initiation after first-line discontinuation in metastatic renal cell carcinoma: insights from a Japanese real-world cohort.

Journal: ESMO real world data and digital oncology

Published: July 13, 2026

Immune-Checkpoint-Inhibitor-Related Bullous Pemphigoid During Avelumab Maintenance Therapy in a Patient With Metastatic Renal Pelvic Carcinoma: A Case Report.

Immune-Checkpoint-Inhibitor-Related Bullous Pemphigoid During Avelumab Maintenance Therapy in a Patient With Metastatic Renal Pelvic Carcinoma: A Case Report.

Journal: IJU case reports

Published: May 20, 2026

Visualizing Baseline Eligibility Across Locally Advanced or Metastatic Urothelial Cancer Trials and Real-World Cohorts.

Visualizing Baseline Eligibility Across Locally Advanced or Metastatic Urothelial Cancer Trials and Real-World Cohorts.

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: May 11, 2026

Real-world Outcomes of Adjuvant Nivolumab in High-risk Bladder and Upper Tract Urothelial Carcinoma after Radical Surgery.

Real-world Outcomes of Adjuvant Nivolumab in High-risk Bladder and Upper Tract Urothelial Carcinoma after Radical Surgery.

Journal: European urology open science

Published: April 19, 2026

Visualizing eligibility gaps between muscle-invasive bladder cancer trials and real-world patients.

Visualizing eligibility gaps between muscle-invasive bladder cancer trials and real-world patients.

Journal: Japanese journal of clinical oncology

Published: March 24, 2026

Association of EVITA with safety in advanced urothelial carcinoma: A multicenter real-world study.

Association of EVITA with safety in advanced urothelial carcinoma: A multicenter real-world study.

Journal: Urologic oncology

Published: February 16, 2026

Presenting postoperative mortality as percentages and natural frequencies (1-in-N) in major urologic cancer surgeries.

Presenting postoperative mortality as percentages and natural frequencies (1-in-N) in major urologic cancer surgeries.

Journal: Urologic oncology

Published: December 27, 2025

Decision tree models combining Bi-parametric vesical imaging reporting and data system and apparent diffusion coefficient metrics for predicting muscle-invasive bladder cancer.

Decision tree models combining Bi-parametric vesical imaging reporting and data system and apparent diffusion coefficient metrics for predicting muscle-invasive bladder cancer.

Journal: Abdominal radiology (New York)

Published: December 15, 2025

Clinical Impact of Preoperative Obesity on Living-Donor Kidney Transplant Recipients in Japan: A Multicenter Experience.

Clinical Impact of Preoperative Obesity on Living-Donor Kidney Transplant Recipients in Japan: A Multicenter Experience.

Journal: Journal of clinical medicine

Published: December 14, 2025

Diagnostic uncertainty of clinical T2 disease and its impact on treatment stratification in upper tract urothelial carcinoma: a multicenter retrospective study.

Diagnostic uncertainty of clinical T2 disease and its impact on treatment stratification in upper tract urothelial carcinoma: a multicenter retrospective study.

Journal: Scientific reports

Published: December 04, 2025

Fournier's Gangrene Following Hydrogel Spacer-related Rectal Ulcer and Fistula in a Patient Undergoing Radiation Therapy for Prostate Cancer.

Fournier's Gangrene Following Hydrogel Spacer-related Rectal Ulcer and Fistula in a Patient Undergoing Radiation Therapy for Prostate Cancer.

Journal: Internal medicine (Tokyo, Japan)

Published: December 03, 2025

Triplet therapy versus androgen receptor pathway inhibitor-doublet therapy in metastatic castration-sensitive prostate cancer: a real-world multicenter retrospective comparison.

Triplet therapy versus androgen receptor pathway inhibitor-doublet therapy in metastatic castration-sensitive prostate cancer: a real-world multicenter retrospective comparison.

Journal: Japanese journal of clinical oncology

Published: November 28, 2025

Showing 1-12 of 295

Last Updated: 09/26/2026